PTSD
Conditions
Brief summary
The primary purpose of this study is to use an unblinded, uncontrolled, 1-month interventional single group pilot study, to assess the possibility of Orgasmic Meditation practice being used as a possible intervention for PTSD. The secondary purpose of this study is to examine if OM is associated with a decrease in the symptoms and self-assessed experiences associated with trauma. The OM Trauma Protocol (OMTP) is designed to systematize the application of Orgasmic Meditation (OM) for individuals seeking relief from a wide variety of problems and/or help them in their pursuit of eudaimonia. The study protocol will evaluate whether OMing (the act of practicing OM) shows potential for being an effective intervention for people suffering from Post-Traumatic Stress Disorder (PTSD).
Interventions
BEHAVIORALOrgasmic Meditation
Orgasmic Meditation (OM) is a structured attention training practice that you do with another person by following a predefined set of detailed instructions. One of the two people participating in the OM must have a clitoris. In this partnered practice, one person strokes the clitoris of another person with the tip of their left index finger for 15 minutes.
Sponsors
Institute of OM Foundation
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Pre and Post Intervention Study with Orgasmic Meditation - a meditation practice
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Adults ≥18 years old * One or more participants of the pair having a diagnosis of PTSD for \> 6 months * Relationship for \> 6 months * Self or partner of female sex * Massachusetts residents * Access and ability to use internet and a video platform called Zoom * No history of doing the practice of OM
Exclusion criteria
* Ongoing or active use of illicit drugs at the time of the study * Self-identify as pregnant * Inability to speak English * Recent hospitalization \< 12 months * Suicidal ideation \< 12 months * Self-harm \< 12 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants who score a 39 or higher using the OM perceived value survey | 4 weeks | feasibility measured by OM perceived value survey |
| Correlation between OM and PTSD symptoms | 4 weeks | Change in PCL-5 Score |
| Number of participants who withdraw from the study | 4 weeks | Safety will be measured by completion rate |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Correlation between anxiety and OM | 4 weeks | Changes in the Generalized Anxiety Disorder 7-Item Scale (GAD-7) |
| Correlation between psychosocial functioning and OM | 4 weeks | Changes in The Brief Inventory for Psychosocial Functioning (B-IPF) |
| Correlation between Eudaimonia and OM | 4 weeks | Changes in Eudaimonia Assessment |
| Correlation between depression and OM | 4 weeks | Changes in The Patient Health Questionnaire: Depression Scale (PHQ-9) |
Other
| Measure | Time frame | Description |
|---|---|---|
| Correlation between OM and tumescence | 4 weeks | Changes in the Tumescence Assessment. Tumescence is the measure of internal energy available in a person to be used for creativity and purpose |
Countries
United States
Outcome results
None listed